InvestorsHub Logo
Followers 19
Posts 1991
Boards Moderated 0
Alias Born 02/25/2017

Re: None

Sunday, 03/26/2017 8:41:00 PM

Sunday, March 26, 2017 8:41:00 PM

Post# of 106837
Trump and the new FDA director are outspokenly pro stem cell. Trump wants to find a way to implement cheaper healthcare, deregulating the FDA and opening the doors to less invasive, less expensive healthcare alternatives. Trump usually gets what he wants, like it or not. Imo us stem cell is in the right place at the right time with the right people to get it done. The new FDA director will want to impress trump, thus FDA RMAT designation and fast track for usrm. Not that far fetched. It's coming.